Other Species / Isoforms
  SHOX (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T5-p
___MEELtAFVsKSF
0 1
SHOX (human) ___MEELtAFVsKSF T5-p
SHOX (dog) ___MEELTAFVSKSF T5
S9-p
EELtAFVsKSFDQKS
0 1
SHOX (human) EELtAFVsKSFDQKS S9-p
SHOX (dog) EELTAFVSKSFDQKS S9
K17-ub
KSFDQKSkDGNGGGG
0 1
SHOX (human) KSFDQKSkDGNGGGG K17-ub
SHOX (dog) KSFDQKSKETGGGGG K17
K30-ac
GGGGGGKkDSITYRE
0 1
SHOX (human) GGGGGGKkDSITYRE K30-ac
SHOX (dog) GGGGGGKKDSITYRE K29
S46-p
LESGLARsRELGTSD
0 1
SHOX (human) LESGLARsRELGTSD S46-p
SHOX (dog) LESGLARSRELGSSE S45
S106-p
EKREDVKsEDEDGQT
Upstream
Downstream
1 1
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, induced
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • apigenin
  • TBB
SHOX (human) EKREDVKsEDEDGQT S106-p
SHOX (dog) EKREDVKSEDEDGQT S105
S120-p
TKLKQRRsRTNFtLE
0 1
SHOX (human) TKLKQRRsRTNFtLE S120-p
SHOX (dog) TKLKQRRSRTNFTLE S119
T125-p
RRsRTNFtLEQLNEL
0 1
SHOX (human) RRsRTNFtLEQLNEL T125-p
SHOX (dog) RRSRTNFTLEQLNEL T124
Y141-p
RLFDETHyPDAFMRE
0 1
SHOX (human) RLFDETHyPDAFMRE Y141-p
SHOX (dog) RLFDETHYPDAFMRE Y140